Senthil Rajappa

1.4k total citations
87 papers, 730 citations indexed

About

Senthil Rajappa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Senthil Rajappa has authored 87 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 28 papers in Pulmonary and Respiratory Medicine and 18 papers in Cancer Research. Recurrent topics in Senthil Rajappa's work include Lung Cancer Treatments and Mutations (10 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Senthil Rajappa is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Senthil Rajappa collaborates with scholars based in India, United States and United Kingdom. Senthil Rajappa's co-authors include Raghunadharao Digumarti, Aju Mathew, D Surekha, Shantveer G. Uppin, S. Vishnupriya, Nageswara Rao Dunna, Sadashivudu Gundeti, Aruna Prayaga, Sundaram Challa and D. N. Rao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Senthil Rajappa

77 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Senthil Rajappa India 16 286 184 146 139 113 87 730
Hedwig M. Blommestein Netherlands 16 296 1.0× 113 0.6× 253 1.7× 175 1.3× 100 0.9× 62 665
David Topolsky United States 15 348 1.2× 123 0.7× 337 2.3× 83 0.6× 93 0.8× 39 884
Jacques Camerlo France 18 448 1.6× 162 0.9× 212 1.5× 172 1.2× 105 0.9× 50 932
Hemant Malhotra India 17 239 0.8× 168 0.9× 430 2.9× 100 0.7× 377 3.3× 72 973
Lothar Müller Germany 13 424 1.5× 269 1.5× 64 0.4× 163 1.2× 80 0.7× 71 850
Raja Pramanik India 14 222 0.8× 126 0.7× 89 0.6× 165 1.2× 35 0.3× 95 574
Raúl Córdoba Spain 20 549 1.9× 128 0.7× 157 1.1× 193 1.4× 255 2.3× 131 1.2k
Marija Bojić Austria 10 364 1.3× 350 1.9× 98 0.7× 283 2.0× 46 0.4× 39 948
D.J. van Spronsen Netherlands 20 403 1.4× 209 1.1× 55 0.4× 119 0.9× 83 0.7× 36 856
Vanita Noronha India 16 456 1.6× 404 2.2× 48 0.3× 148 1.1× 115 1.0× 97 1.0k

Countries citing papers authored by Senthil Rajappa

Since Specialization
Citations

This map shows the geographic impact of Senthil Rajappa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Senthil Rajappa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Senthil Rajappa more than expected).

Fields of papers citing papers by Senthil Rajappa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Senthil Rajappa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Senthil Rajappa. The network helps show where Senthil Rajappa may publish in the future.

Co-authorship network of co-authors of Senthil Rajappa

This figure shows the co-authorship network connecting the top 25 collaborators of Senthil Rajappa. A scholar is included among the top collaborators of Senthil Rajappa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Senthil Rajappa. Senthil Rajappa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prabhash, Kumar, Shekar Patil, Prabhat Singh Malik, et al.. (2025). Safety of nivolumab in treating Indian patients with non-small-cell lung carcinoma and renal cell carcinoma: A prospective multicenter study. Cancer Research Statistics and Treatment. 8(1). 12–20.
2.
Parikh, Purvish M., Akhil Kapoor, Tarini Prasad Sahoo, et al.. (2024). Consensus Guidelines for the Use of Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors in the Management of Hormone Receptor Positive (HR+ve), Her2−ve Early Breast Cancer (EBC). SHILAP Revista de lepidopterología. 14(1). 45–52. 1 indexed citations
3.
Mandava, Anitha, et al.. (2024). Multimodality Imaging in the Diagnosis and Staging of Gestational Choriocarcinoma. SHILAP Revista de lepidopterología. 35(1). 148–158. 1 indexed citations
4.
Bhardwaj, Prarthna V, et al.. (2023). Breast Cancer in India. Hematology/Oncology Clinics of North America. 38(1). 123–135. 5 indexed citations
5.
Rajappa, Senthil, Jaya Ghosh, Atul Batra, et al.. (2023). 372P Prevalence of BRCA1 and BRCA2 mutation among Indian breast cancer patients: A multicentre cross-sectional study. Annals of Oncology. 34. S331–S331.
6.
Ramaswamy, Anant, Anand V. Kulkarni, George John, et al.. (2023). Survival of Trial-Like and Non–Trial-Like Patients With Immunotherapy in Advanced Hepatocellular Carcinoma in Real World: A Collaborative Multicenter Indian Study (IMHEP). JCO Global Oncology. 9(9). e2300215–e2300215. 4 indexed citations
7.
Rotow, Julia, Jyoti D. Patel, Helena A. Yu, et al.. (2023). Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR -Mutant and RET Fusion-Positive Lung Cancers. Clinical Cancer Research. 29(16). 2979–2987. 26 indexed citations
8.
Parikh, Purvish M., Govind Babu, Randeep Singh, et al.. (2023). Consensus guidelines for the management of HR-positive HER2/neu negative early breast cancer in India, SAARC region and other LMIC by DELPHI survey method. BMC Cancer. 23(1). 714–714. 3 indexed citations
9.
Rajappa, Senthil, et al.. (2022). Post-treatment Residual Clinicopathological Outcomes in Testicular Germ Cell Tumours. Indian Journal of Surgical Oncology. 13(3). 505–510.
10.
Murthy, Sudha, et al.. (2022). Frequency of Nucleophosmin 1 Expression by Immunohistochemistry in Acute Myeloid Leukemia. Indian Journal of Hematology and Blood Transfusion. 38(4). 643–648.
11.
Thammineedi, Subramanyeshwar Rao, et al.. (2021). Influence of neoadjuvant therapy on outcomes in patients with resectable carcinoma of esophagus and gastro‐esophageal junction from a tertiary cancer care center in India. Journal of Surgical Oncology. 123(7). 1547–1557. 2 indexed citations
12.
Epton, Tracy, et al.. (2020). Indian patient use of cancer euphemisms: Association with psychological outcomes and health behaviours. Psycho-Oncology. 29(7). 1193–1200. 3 indexed citations
13.
Rajappa, Senthil, et al.. (2019). Efficacy of Yoga and Naturopathy as an Adjuvant in the Management of Non-Hodgkin’s Lymphoma. International Journal of Health Sciences and Research. 9(9). 172–182. 2 indexed citations
14.
Raju, K. V. V. N., et al.. (2019). The Impact of Stage and Molecular Subtypes on Survival Outcomes in Young Women with Breast Cancer. Journal of Adolescent and Young Adult Oncology. 8(5). 628–634. 3 indexed citations
15.
16.
17.
Challa, Sundaram, et al.. (2014). Spectrum of malignancies in human immunodeficiency virus – positive patients at a Tertiary Care Centre in South India. Indian Journal of Cancer. 51(4). 459–459. 2 indexed citations
18.
Murthy, Sudha, et al.. (2012). A novel 11;18 translocation in a case of acute myeloid leukemia with maturation. Indian journal of human genetics. 18(3). 369–369. 1 indexed citations
19.
Surekha, D, et al.. (2011). NQO1*2 (NAD(P)H: quinone oxidoreductase 1) polymorphism and its influence on acute leukemia risk. 3(3). 0–0. 2 indexed citations
20.
Rao, D. N., et al.. (2010). Association of an MDR1 gene (C3435T) polymorphism with acute leukemia in India.. PubMed. 11(4). 1063–6. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hedwig M. Blommestein Breakdown of academic impact, for papers by David Topolsky Breakdown of academic impact, for papers by Jacques Camerlo Breakdown of academic impact, for papers by Hemant Malhotra Breakdown of academic impact, for papers by Lothar Müller Breakdown of academic impact, for papers by Raja Pramanik Breakdown of academic impact, for papers by Raúl Córdoba Breakdown of academic impact, for papers by Marija Bojić Breakdown of academic impact, for papers by D.J. van Spronsen Breakdown of academic impact, for papers by Vanita Noronha
Rankless by CCL
2026